Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
IONIS PTP1BRx
Cat. No.:
OB0425LY-216
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
IONIS PTP1BRx is an antisense protein tyrosine phosphatase 1B (PTP-1B) inhibitor with antidiabetic activity.
Synonyms:
1403406-29-0; ISIS 404173
CAS No.:
1403406-29-0
Specification
Target:
Phosphatase
Pathway:
Metabolic enzyme/Protease
Storage:
Storage at -20°C.
Applications:
IONIS PTP1BRx can be used in the study of metabolic diseases, especially in the treatment of diabetes and obesity, and may play a role by modulating the insulin signaling pathway.
